openPR Logo
Press release

Cancer Biological Therapy Market to Exhibit Impressive Growth During 2016-2026

05-28-2018 11:37 AM CET | Health & Medicine

Press release from: Future Market Insights

Cancer Biological Therapy Market to Exhibit Impressive Growth

Biological cancer therapies use the body’s immune system, either directly or indirectly, to fight cancer or to lessen the side effects that may be caused by some cancer treatments. It is also called biotherapy or biological response modifiers. Interferons and monoclonal antibodies are among the most promising biological approaches to cancer treatment. Biological therapy works by stimulating, boosting, restoring or acting like the body’s immune system response against cancer cells. Cancer is a leading cause of death worldwide. Factors that contribute to geographic differences in cancer occurrence include the prevalence of risk factors, the availability and use of diagnostic tests, variations in the age structure of the population, and the availability and quality of treatment. According to WHO, approximately 14 million new cases and 8.2 million cancer related deaths in 2012. Tobacco use is the most important risk factor for cancer causing around 20% of global cancer deaths and around 70% of global lung cancer deaths.

Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-2044

Cancer Biological Therapy Market: Drivers and Restraints

The factors such as growing prevalence of cancer, continuous patent expiry of cancer drugs, rising impact of biosimilars and increasing demand of biological and targeted drug therapies will drive the overall cancer biological therapy market. According to WHO, the number of new cancer cases is projected to rise 70% in the coming two decades, mainly due to increased use of tobacco and alcohol consumption. However, the threat of failure in treatment, the high cost of drug development, the adverse effects of cancer drug therapy, particularly chemotherapy and stricter government regulations will hinders the overall cancer biological therapy market growth globally.

Cancer Biological Therapy Market: Segmentation

The global Cancer Biological Therapymarket is classified on the basis of Product type, distribution channels and regional presence.

Segmentation based on product type:

Vaccines

Cancer growth blockers

Tyrosine kinase inhibitors

Proteasome inhibitors

mTOR inhibitors

Monoclonal antibodies

Naked monoclonal antibodies

Conjugated monoclonal antibodies

Bispecific monoclonal antibodies

Cytokines

Interferons

Interleukins

Blood cell growth factors

Lenograstim

Filgrastim

Gene therapy

Segmentation based on distribution channels:

Hospital pharmacies

Retail pharmacies

Mail order pharmacies

Cancer Biological Therapy Market: Overview

The immune system protects a person from infection and disease. The Biological therapies are used to lessen the spread and lower the risk of recurrence for some cancers, slow the growth, control symptoms of cancer, deliver radioactive substances or chemotherapy drugs directly to a tumour lessen and some of the side effects from cancer treatments. Immune system recognize antigens on the surface of viruses, bacteria, other germs and cancer cells. Antigens mark these cells as being different (foreign) so the immune system can find them. The immune system reacts to these antigens and destroys the cells they are attached to. According to Globocan, in economically developed countries, 58% of all newly diagnosed cancer cases occur at 65 years of age and older, compared with 40% in developing countries. When countries are grouped according to income, cancer is the second leading cause of death in high-income countries and the third leading cause of death in low- and middle-income countries. Among females, the most common cancer sites were either breast or cervical cancer, with the exceptions of South Korea (thyroid), Mongolia and Laos (liver) and China and North Korea (lung).

Cancer Biological Therapy Market: Regional Overview

Geographically, the market is dominated by North America, followed by Europe, Asia Pacific. Growth in the North American segment is primarily driven by presence of large number of cancer biological drug and vaccine manufacturers, increasing disposable income, affordable cancer treatment facility and growing number of health insurance coverage for life-threatening diseases. According to National Cancer Institute (NCI) an estimated 16, 85,210 new cases will be diagnosed in 2016, in the US. Europe is the second largest market .Asia pacific is expected to grow at a highest rate due to increasing prevalence of cancer patient, better healthcare facilities and growing number of insurance coverage. Japan contributes largest share in cancer treatment market in Asia Pacific due to high prevalence of cancer in Japanese population.

Request TOC: https://www.futuremarketinsights.com/toc/rep-gb-2044

Cancer Biological Therapy Market: Key Players

Some of the major players operating in the market for Cancer Biological Therapy Market are F. Hoffmann-La Roche AG, Novartis International AG, Merck & Co., Inc., Amgen Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation and others

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biological Therapy Market to Exhibit Impressive Growth During 2016-2026 here

News-ID: 1063578 • Views:

More Releases from Future Market Insights

Polygon Mirror Scanner Motor Market Set to Hit USD 88.5 Million by 2035, Powered by Advanced Imaging and Office Tech
Polygon Mirror Scanner Motor Market Set to Hit USD 88.5 Million by 2035, Powered …
The global polygon mirror scanner motor market is experiencing robust growth, forecasted to rise from USD 55.9 million in 2025 to USD 88.5 million by 2035, which represents a nearly 1.6-fold increase over the assessment period. This remarkable expansion is shaped by the widespread adoption of next-generation scanning technologies and the rapid digital transformation across the printing and office equipment industries. As businesses renew their focus on speed, accuracy, and
Global p-Hydroxybenzoic Acid Market to Approach USD 400 Million by 2035, Driven by Polymer and Textile Demand
Global p-Hydroxybenzoic Acid Market to Approach USD 400 Million by 2035, Driven …
The global p-Hydroxybenzoic Acid (PHBA) market is entering a new era of growth, expected to rise from USD 213.0 million in 2025 to USD 399.8 million by 2035, showcasing a compound annual growth rate of 6.5%. This surge is underpinned by PHBA's flourishing adoption in polymer synthesis, textile processing, and supporting industries seeking high-performance and sustainable chemical solutions. As organizations shift towards advanced materials with enhanced durability, thermal stability, and
Sustainable Growth Drives Castor Oil Polyol Market to USD 418.8 Million by 2035 as Manufacturers Innovate for Green Industries
Sustainable Growth Drives Castor Oil Polyol Market to USD 418.8 Million by 2035 …
The castor oil polyol market is set to reshape the landscape of bio-based chemicals, growing from a value of USD 254.7 million in 2025 to USD 418.8 million by 2035. This represents a robust CAGR of 5.1% over the decade, with expansion driven by surging demand across chemical, automotive, construction, and coatings sectors. The market's early growth, spanning 2021 to 2025, reflects steady adoption as sustainable polyols substitute petroleum-based alternatives,
Global Fifth Wheel Coupling Market to Hit USD 1.2 Billion by 2035 Driven by Smart Fleet Innovations
Global Fifth Wheel Coupling Market to Hit USD 1.2 Billion by 2035 Driven by Smar …
The global Fifth Wheel Coupling Market continues to evolve as the logistics and transport sectors demand more efficient, safe, and smart towing systems. Valued at USD 547.3 million in 2020 and reaching USD 672.6 million by 2024, the market is projected to expand at a 6.0% CAGR from 2025 to 2035, ultimately achieving a valuation of USD 1,238.6 million. At the heart of this growth lies the critical role of fifth

All 5 Releases


More Releases for Biological

Biological Control Market Projected to Witness Massive Growth - Koppert Biologic …
Biological Control Market Snapshot The Biological Control Market is projected to reach USD 9.7 billion by 2032, growing at a CAGR of 9.4% from 2025 to 2032. Coherent Market Insights proudly presents its latest Biological Control Market Research Report, delivering a detailed examination of the U.S. Biological Control Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,
Biological and Chemical Indicators Market - Beyond Measure: Biological and Chemi …
Newark, New Castle, USA: The "Biological and Chemical Indicators Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological and Chemical Indicators Market: https://www.growthplusreports.com/report/biological-and-chemical-indicators-market/8887 This latest report researches the
Biological APIs Market - Biological APIs: The Driving Force Behind Cutting-Edge …
Newark, New Castle, USA: The "Biological APIs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological APIs Market: https://www.growthplusreports.com/report/biological-apis-market/8769 This latest report researches the industry structure, sales, revenue,
Human Immunoglobulin for Intravenous Injection Market demand and future scope wi …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global Human Immunoglobulin for Intravenous Injection. On the basis of historic growth analysis and current scenario of Human Immunoglobulin for Intravenous Injection place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from
Global Biological safety testing Market | Global Biological safety testing Indus …
Biologics are termed as those product that attained from living organism and feature a differentiate set of properties. The biologics want extreme safety from contamination thus biological safety testing is incorporate timely to make sure its safety quality and non-contamination of vaccines & biopharmaceuticals, along with comply with the bound rules applicable on it. A number of the foremost biological tests are sterility testing, bioburden testing, residual host contaminant detection
Meningococcal Infections Vaccine Market Insights, Forecast to 2025 : Sanofi-Past …
Researchmoz added Most up-to-date research on "Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025" to its huge collection of research reports. This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Infections Vaccine in these regions. This research report categorizes the global Meningococcal Infections Vaccine market